×
Positron Net Profit Margin 2010-2025 | POSC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Positron net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Positron Net Profit Margin 2010-2025 | POSC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Positron net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$186.1B
Intuitive Surgical (ISRG)
$169.7B
IDEXX Laboratories (IDXX)
$51.8B
Edwards Lifesciences (EW)
$47.8B
Alcon (ALC)
$39.4B
IQVIA Holdings (IQV)
$32.4B
DexCom (DXCM)
$29.5B
Mettler-Toledo (MTD)
$26.8B
STERIS (STE)
$24.1B
Waters (WAT)
$18B
SONOVA HOLDING (SONVY)
$17.4B
Hologic (HOLX)
$14.9B
Penumbra (PEN)
$10.6B
Globus Medical (GMED)
$8.3B
Sysmex ADR (SSMXY)
$7.9B
Masimo (MASI)
$7.6B
Teleflex (TFX)
$5.6B
Glaukos (GKOS)
$5.5B
TransMedics (TMDX)
$3.9B
Integer Holdings (ITGR)
$3.8B
LivaNova (LIVN)
$3.1B
Veracyte (VCYT)
$2.4B
Alphatec Holdings (ATEC)
$2.4B
PROCEPT BioRobotics (PRCT)
$2.2B
Artivion (AORT)
$2.1B
Nihon Kohden (NHNKY)
$2B
Elekta AB (EKTAY)
$1.8B
Integra LifeSciences Holdings (IART)
$1.2B
Paragon 28 (FNA)
$1.1B
OPKO Health (OPK)
$1.1B